Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Hepatology
Gastroenterology
Questions discussed in this category
Is there benefit to aggressively treating hemochromatosis in a patient who has already progressed to cirrhosis at the time of diagnosis?
1 Answer available
Do you obtain liver biopsy to confirm the diagnosis of cirrhosis if cirrhotic liver morphology is noted on imaging?
2 Answers available
Do you recommend the use of SGLT2 inhibitors to reduce the risk of liver cirrhosis in patients with Type 2 diabetes mellitus?
1 Answer available
23473
23049
22838
Papers discussed in this category
International journal of molecular sciences, 2022 Mar 13
SGLT-2 Inhibitors in NAFLD: Expanding Their Role beyond Diabetes and Cardioprotection.
Archives of internal medicine, 2006 Feb 13
Screening for hemochromatosis in asymptomatic subjects with or without a family history.
Related Topics in Hepatology
General Hepatology
Metabolic Dysfunction-Associated Liver Diseases
Autoimmune Liver Disease
Alcohol-associated Liver Disease
Transplant Hepatology
Liver Tumors
Portal Hypertension
Viral Hepatitis
Genetic Liver Disease
Gastroenterology